Jerome Dvonch
Director of Finance/CFO presso SONOMA PHARMACEUTICALS, INC.
Patrimonio netto: 2 574 $ in data 31/03/2024
Profilo
Jerome J.
Dvonch is currently the Chief Financial Officer at Sonoma Pharmaceuticals, Inc. He previously held financial positions at Protein Design Labs, Exelixis, NeoGenomics Laboratories, and PharmChem, Inc. He also served as the Controller and SVP-Finance & Accounting at Spine Center Atlanta.
Dvonch holds an MBA from the University of Rochester and an undergraduate degree from Niagara University.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 29/12/2023 | 15 505 ( 0.10% ) | 2 574 $ | 31/03/2024 |
Posizioni attive di Jerome Dvonch
| Società | Posizione | Inizio |
|---|---|---|
| SONOMA PHARMACEUTICALS, INC. | Director of Finance/CFO | 08/09/2020 |
Precedenti posizioni note di Jerome Dvonch
| Società | Posizione | Fine |
|---|---|---|
| SONOMA PHARMACEUTICALS, INC. | Director of Finance/CFO | 03/10/2022 |
NeoGenomics Laboratories, Inc.
 NeoGenomics Laboratories, Inc. Medical/Nursing ServicesHealth Services NeoGenomics Laboratories, Inc. operates as a cancer diagnostics and pharma services company. It serves oncologists, pathologists, pharmaceutical companies, academic centers, and others with diagnostic, prognostic and predictive testing. The company was founded in 2002 and is headquartered in Fort Myers, FL. | Director of Finance/CFO | 01/07/2015 |
Protein Design Labs, Inc.
 Protein Design Labs, Inc. Pharmaceuticals: MajorHealth Technology Protein Design Labs, Inc. is a biopharmaceutical company focused on the research, development and commercialization of novel therapies for inflammation and autoimmune diseases, acute cardiac conditions and cancer. PDL markets several biopharmaceutical products in the United States through its hospital sales force and wholly-owned subsidiary, ESP Pharma, Inc. As a company of development of humanized antibodies, It has licensed its patents to numerous pharmaceutical and biotechnology companies, some of which are now paying royalties on net sales of licensed products. | Corporate Officer/Principal | 01/07/2005 |
| EXELIXIS, INC. | Corporate Officer/Principal | 01/06/2004 |
| Spine Center Atlanta | Comptroller/Controller/Auditor | - |
Formazione di Jerome Dvonch
| Rochester Christian University | Masters Business Admin |
| Niagara University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 4 |
|---|---|
| PHARMCHEM, INC. | Health Services |
| NEOGENOMICS, INC. | Health Services |
| EXELIXIS, INC. | Health Technology |
| SONOMA PHARMACEUTICALS, INC. | Health Technology |
| Aziende private | 3 |
|---|---|
Protein Design Labs, Inc.
Protein Design Labs, Inc. Pharmaceuticals: MajorHealth Technology Protein Design Labs, Inc. is a biopharmaceutical company focused on the research, development and commercialization of novel therapies for inflammation and autoimmune diseases, acute cardiac conditions and cancer. PDL markets several biopharmaceutical products in the United States through its hospital sales force and wholly-owned subsidiary, ESP Pharma, Inc. As a company of development of humanized antibodies, It has licensed its patents to numerous pharmaceutical and biotechnology companies, some of which are now paying royalties on net sales of licensed products. | Health Technology |
NeoGenomics Laboratories, Inc.
NeoGenomics Laboratories, Inc. Medical/Nursing ServicesHealth Services NeoGenomics Laboratories, Inc. operates as a cancer diagnostics and pharma services company. It serves oncologists, pathologists, pharmaceutical companies, academic centers, and others with diagnostic, prognostic and predictive testing. The company was founded in 2002 and is headquartered in Fort Myers, FL. | Health Services |
| Spine Center Atlanta |
- Borsa valori
- Insiders
- Jerome Dvonch
